This site is intended for healthcare professionals
GPnotebook TV
GPnotebook
Listen or subscribe on
LOG IN
Listen or subscribe on

Diabetes and endocrinology

Podcast 3: The role of the diabetes specialist nurse: supporting people with diabetes to access diabetes technology (Content sponsored by Dexcom)

Listen to the experts explore some of the potential barriers faced by people living with diabetes and consider ideas on how to tackle these. They also go on to discuss the initiation of people on diabetes technologies and highlight the simple and easy onboarding process for the Dexcom ONE real-time continuous glucose monitoring (rtCGM) system.
Sponsored
  • LBL-1002981 Rev001 | April 2023

Podcast 2: The role of the clinical pharmacist in diabetes management: identifying patients who would benefit from real-time continuous glucose monitoring (rtCGM) and initiating it in primary care (Content sponsored by Dexcom)

Join the diabetes experts as they discuss the important role that clinical pharmacists play in the management of diabetes care. Listen in as they delve into ways to identify those patients that would benefit most from rtCGM and explore the role that primary care has to play in getting patients started on devices like Dexcom ONE.
Sponsored
  • LBL-1002980 Rev001 | April 2023

Podcast 1: What is real-time continuous glucose monitoring? An introduction to the Dexcom podcast series (Content sponsored by Dexcom)

Two diabetes experts share how glucose monitoring has evolved into the real-time continuous glucose monitoring (rtCGM) of today, and why HCPs should stay up-to-date with the latest in rtCGM with our podcast series. Hear them review the mechanism of rtCGM and the clinical evidence that led to rtCGM being recommended in the latest NICE guidelines for both T1D and T2D.
Sponsored
  • LBL-1002835 Rev001 | February 2023

The role of second-generation basal insulins and CGM in optimising glycaemic control: The InRange study (Promotional content from Sanofi)

In this episode, Professor Pratik Choudhary summarises the findings from the InRange study, the first randomised, Phase 4 study to use Time in Range as the primary endpoint to compare second-generation basal insulin analogues, Toujeo (insulin glargine 300 U/mL) and insulin degludec 100 U/mL, in people with type 1 diabetes.¹
Sponsored
  • MAT-XU-2201784 (v1.0) | October 2022

Ep 45 – Detecting and managing non-alcoholic fatty liver disease in type 2 diabetes

In this episode, which has been recorded for Chronic Conditions Month 2022, Dr Steve Holmes (GP, Shepton Mallet and Clinical Respiratory Lead, NHS England South West and NHS Somerset) and Dr Sarah Davies (GPwSI in Diabetes, Cardiff) discuss non-alcoholic fatty liver disease (NAFLD) in the context of diabetes. How is NAFLD best detected, diagnosed and managed in high-risk populations? How can primary care professionals identify those who are at risk of fibrosis?
The content of this website is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. Any distribution or duplication of the information contained herein is strictly prohibited.

Copyright © 2023 Oxbridge Solutions Ltd. All rights reserved.

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.

GPnotebook_podcast_white-text

Would you like to receive updates about new podcast episodes by email? (You can unsubscribe at any time)